Companies /Healthcare

Medtronic Plc

NYSE: MDT Medical Devices
$87.10
▼ $0.87 (−0.99%) today
Markets closed · 5:51pm ET

24/7 Wall St. View

Price Prediction $106.77 +21.4% Our analysts’ 12-month view: target, optimistic case, and floor. MDT price prediction → Earnings Beat +4.5% EPS vs. the estimate, revenue, and how the market reacted. MDT earnings history →

MDT at a Glance

Valuation
Market cap
$112.5B
P/E ratio
21.6
Dividend yield
3.30%
Profitability
Revenue (TTM)
$37.5B
Profit margin
13.9%
EPS (TTM)
$4.07
Price
52-week range
$72 – $103
24/7 target
$106.77
Street target
$104.83
Earnings
Next report
Nov 16, 2026
Q1 2027 EPS
$1.45
vs. $1.39 est.
+4.5%

Headquartered in Building Two, Galway Fiscal year ends April NYSE: MDT medtronic.com

About Medtronic

Medtronic plc is a global healthcare technology company that develops and manufactures medical devices and therapies across cardiovascular, neuroscience, medical surgical, and diabetes care. The company's portfolio spans cardiac devices (including pacemakers, defibrillators, cardiac ablation systems, and structural heart solutions), cranial and spinal surgical technologies, surgical robotics, neuromodulation therapies, patient monitoring systems, insulin pumps, and continuous glucose monitors. Medtronic serves healthcare systems in more than 150 countries with approximately 95,000 employees. The company is in the process of separating its Diabetes business through potential capital markets transactions, which may include a spin-off, split-off, or offering. In fiscal 2027, the Cardiovascular Portfolio was reorganized into Electrophysiology Therapies, Interventional Cardiology Therapies, CardioVascular Surgery, and Peripheral Vascular Health divisions. The company trades on the NYSE under the ticker MDT. Updated

Revenue by Segment · Q1 2027
  1. Cardiovascular Portfolio40%
  2. Neuroscience Portfolio27%
  3. Medical Surgical Portfolio23%
  4. Diabetes9%

Latest Activity

Jim Cramer
PodcastMad Money w/ Jim CramerJim Cramer · 44 min

Mad Money w/ Jim Cramer 10/1/26

  • Cramer still buys Palantir at $190 after the stock gained 60% in Q3 and stalled short of his $250 target
  • Salesforce, up 46.5%, called the better SaaS-apocalypse rebound than Veeva at 30 times earnings
  • Caterpillar's 24% Q3 profit taking framed as a buying chance on data center engine demand
  • IBM, down 22% on its miss, gets the wait-a-quarter rule; Home Depot stays hostage to rates

Cramer wants to add software as the bounce-back trade and the beaten-down industrial names tied to data center power. He also warns that rising rates are the real threat heading into earnings season in a couple of weeks.

Read more
MDTMedtronic
Q1 2027
EPS
$1.45
est $1.39+4.5%
Revenue
$9.76B
est $9.54B+2.2%

Medtronic raised its FY27 organic revenue growth outlook to 7.25% to 7.75% after beating on both lines, and that guidance lift matters more than a fifth straight EPS beat. Cardiovascular carried it, led by Electrophysiology Therapies revenue up 29.5%.

Quarterly EPS — reported vs estimate
Read more
Earnings on deck — Aug 31–4
79 companies37 before open42 after close

Seventy-nine companies report next week, and Tuesday morning does the heavy lifting: NIO and Medtronic both deliver before the open, one a read on Chinese EV demand, the other on medtech spending. Monday starts quieter with SAIC and a run of small-cap international names.

  • SAICScience Applications International CorporationMon Aug 31Before open
  • BLRXBioLineRx Ltd.Mon Aug 31Before open
  • LXLexinFintech Holdings Ltd.Mon Aug 31Before open
  • NEXCFNextech3D.ai Mon Aug 31Before open
  • PLSMPULSENMORE LTDMon Aug 31Before open
  • SYSo-Young International Inc.Mon Aug 31Before open
  • CANGCango Inc.Mon Aug 31After close
  • PXSPyxis Tankers Inc.Mon Aug 31After close
  • NIONIO Inc.Tue Sep 1Before open
  • SSLSasol LtdTue Sep 1Before open
  • RZLVRezolve AI plcTue Sep 1Before open
  • MDTMedtronic plcTue Sep 1Before open
  • MMEDMiniMed Tue Sep 1Before open
  • HMRHeidmar Maritime Holdings Corp.Tue Sep 1Before open
  • YEXTYext, Inc.Tue Sep 1Before open
Read more

MDT Coverage

Load More

Frequently Asked Questions

What does Medtronic do?

Medtronic plc is a global healthcare technology company that develops and manufactures medical devices and therapies across cardiovascular, neuroscience, medical surgical, and diabetes care.

What is the MDT stock price target?

24/7 Wall St.'s 12-month price target for MDT is $106.77, rated Buy. The Wall Street consensus target is $104.83. MDT price prediction →